DE69133172T2 - Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum - Google Patents

Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum

Info

Publication number
DE69133172T2
DE69133172T2 DE69133172T DE69133172T DE69133172T2 DE 69133172 T2 DE69133172 T2 DE 69133172T2 DE 69133172 T DE69133172 T DE 69133172T DE 69133172 T DE69133172 T DE 69133172T DE 69133172 T2 DE69133172 T2 DE 69133172T2
Authority
DE
Germany
Prior art keywords
necrophorum
treat liver
necrosis caused
liver necrosis
bacterin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133172T
Other languages
English (en)
Other versions
DE69133172D1 (de
Inventor
John N Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of DE69133172D1 publication Critical patent/DE69133172D1/de
Application granted granted Critical
Publication of DE69133172T2 publication Critical patent/DE69133172T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69133172T 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum Expired - Fee Related DE69133172T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53489490A 1990-06-07 1990-06-07

Publications (2)

Publication Number Publication Date
DE69133172D1 DE69133172D1 (de) 2003-01-23
DE69133172T2 true DE69133172T2 (de) 2003-04-30

Family

ID=24131961

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69133172T Expired - Fee Related DE69133172T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
DE69116606T Expired - Fee Related DE69116606T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69116606T Expired - Fee Related DE69116606T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung

Country Status (8)

Country Link
US (1) US6132709A (de)
EP (2) EP0460480B1 (de)
AU (1) AU644440B2 (de)
CA (1) CA2043932C (de)
DE (2) DE69133172T2 (de)
ES (2) ES2084057T3 (de)
IE (1) IE72181B1 (de)
NZ (1) NZ238378A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196654T1 (de) * 1992-06-26 2000-10-15 Univ Kansas State Fusobacterium necrophorum leukotoxoid vakzin
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
BR9610775A (pt) * 1995-06-07 1999-07-13 Univ Kansas State Vacinas de actinomyces pyogenes e de actinomyces pyogenes/fusobacterium necrophorum para imunizar gado e carneiros
US5861162A (en) * 1995-06-07 1999-01-19 Kansas State University Research Foundation Multivalent inocula for lessening incidence of liver abscesses in cattle
US6632439B2 (en) * 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
ES2452471T3 (es) * 2008-01-18 2014-04-01 Werner Lubitz Procedimiento de producción de fantasmas bacterianos (BG) utilizando beta-propiolactona (BPL) para la inactivación final
WO2011044576A2 (en) 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
BR112015012288B1 (pt) 2012-11-29 2022-07-26 Cornell University Uso de uma composição veterinária

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA984293A (en) * 1971-08-20 1976-02-24 Richard W. Moore Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom
FR2174745A1 (en) * 1972-03-09 1973-10-19 Inst Elevage Med Vet Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
US4061751A (en) * 1976-07-22 1977-12-06 American Cyanamid Company 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
EP0310316B1 (de) * 1987-09-28 1995-02-01 Beecham Inc. TGEV-Virus vom Schwein als Impfstoff für Hunde

Also Published As

Publication number Publication date
AU644440B2 (en) 1993-12-09
DE69133172D1 (de) 2003-01-23
DE69116606D1 (de) 1996-03-07
EP0460480A2 (de) 1991-12-11
DE69116606T2 (de) 1996-05-30
IE72181B1 (en) 1997-03-26
NZ238378A (en) 1992-12-23
EP0460480B1 (de) 1996-01-24
EP0674905A2 (de) 1995-10-04
EP0460480A3 (en) 1992-04-01
ES2186694T3 (es) 2003-05-16
AU7817791A (en) 1991-12-12
ES2084057T3 (es) 1996-05-01
IE911940A1 (en) 1991-12-18
EP0674905B1 (de) 2002-12-11
CA2043932C (en) 2006-09-12
CA2043932A1 (en) 1991-12-08
EP0674905A3 (de) 1995-12-06
US6132709A (en) 2000-10-17

Similar Documents

Publication Publication Date Title
DE3674308D1 (de) Biozide zusammensetzungund verfahren zur behandlung von wasser.
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
DE3486229D1 (de) Verfahren zur Herstellung von L-Phenylalanin.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
IT7925699A0 (it) Composizioni fotografiche di sbianca, e metodi per trattamento fotografico.
DE69133172T2 (de) Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
DE59106640D1 (de) Verfahren zur Herstellung von 1,3-Diketonen.
DE69112631D1 (de) Verfahren zur isomerisierung von alkylaromaten.
DE59103046D1 (de) Verfahren zur Herstellung von Alkylglycosiden und Alkylpolyglycosiden.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
DE59101444D1 (de) Verfahren zur Herstellung von p-Amino-phenolen.
DE59402601D1 (de) Verfahren zur Herstellung von in alpha-Stellung durch einen Alkylrest substituierten Aldehyden
DE69121206D1 (de) Eintkaffeinierungsverfahren von kaffee durch eine säurebehandlung
DE69108044D1 (de) Verfahren zur verbesserung der fliessencharakteristik von kristallinem ibuprofen.
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
IT7926896A0 (it) Perfezionamento nelle camere per il trattamento di pezzi.
DE3481324D1 (de) Vorrichtung zur herstellung von einkristallinem galliumarsenid und einkristallines galliumarsenid hergestellt durch diese vorrichtung.
ATA38889A (de) Vorrichtung zur herstellung von durch zugabe von binde- oder abdichtemitteln verdichteten bodenabschnitten
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
ATE73765T1 (de) Verfahren zur herstellung von 2-nitro-5-phenoxy-n-alkylsulfonylbenzamiden durch nitrierung.
DE68908445D1 (de) Mittel zur behandlung von lebererkrankungen.
DE69109791D1 (de) Verfahren zur Herstellung von Monohalogenalkanoylferrocenen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee